Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
This study revealed that EMMPRIN/CD147 mediates HNSCC migration by its interaction with S100A9. In addition, the results showed anti-tumor effect of EMMPRIN/CD147 inhibition, and also suggest the EMMPRIN inhibition increases anti-tumor effects of EGFR targeting in head and neck cancer. An analysis based on clinial samples showed that EMMPRIN expression significantly correlated with lymph node metastases of stage I and II squamous cell carcinoma of the tongue.
|